Cite
MLA Citation
Tom Lillie et al.. “329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A355. http://access.bl.uk/ark:/81055/vdc_100144711762.0x000003